BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Ischemia
,
Leukocyte
,
Anticancer prodrugs
,
Vitamin E
,
CXCL2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Interferon beta 1b
Summary
General Info
Curated Studies
Most Correlated Studies
Multiple sclerosis patients in remission and relapse
PBMCs from multiple sclerosis patients treated with Betaferon or Rebif
Multiple sclerosis patients receiving subcutaneous Interferon-beta-1b therapy
Foreskin fibroblast BJ cells depleted of Sp100 and treated with IFN-beta
Multiple sclerosis patients receiving Interferon-beta therapy expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Re…
Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta…
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combin…
Paediatric viral myocarditis successfully treated with interferon beta-1b and corticoids.
Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospecti…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Natalizumab De-escalation With Interferon Beta-1b
MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclero…
Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-B…
Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multipl…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ